Skip to main content
Powered by
buzzwords.news
(
US Patent 11,232,363 B2
) · created by
d-e-v.com
buzzwords.technology
main_menu
Home
Channels
Personalize
Headlines
Alexa Skill
Search
Search
Home
Headlines
Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates
posted:
Mon, 02/26/2024 - 17:10 EST
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Seres Therapeutics Appoints Marella Thorell As New CFO Following Retirement Of David Arkowitz
posted:
Mon, 02/26/2024 - 07:15 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Larimar Therapeutics (LRMR) Price Target Increased by 75.76% to 22.19
posted:
Sat, 02/24/2024 - 04:25 EST
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Iterum Therapeutics (ITRM) Price Target Increased by 550.00% to 6.63
posted:
Fri, 02/23/2024 - 19:34 EST
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Janux Therapeutics, Inc. (JANX) Moves 5.6% Higher: Will This Strength Last?
posted:
Wed, 02/21/2024 - 02:39 EST
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Axsome Therapeutics (AXSM) Q4 2023 Earnings Call Transcript
posted:
Tue, 02/20/2024 - 18:00 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Viking Therapeutics Reaches Analyst Target Price
posted:
Mon, 02/19/2024 - 10:58 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics
posted:
Mon, 02/19/2024 - 09:15 EST
by:
Nasdaq Technology
#channels::
#All
,
#Business
,
#Nasdaq
,
#Technology
,
#NasdaqTechnology
,
#Stocks
Sarepta Therapeutics (SRPT) Moves 7.8% Higher: Will This Strength Last?
posted:
Mon, 02/19/2024 - 03:26 EST
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Analysts Say Intellia Therapeutics Stock Could Rise 157% This Year, but Will It Happen?
posted:
Sat, 02/17/2024 - 01:59 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Commit To Buy United Therapeutics At $210, Earn 7.9% Annualized Using Options
posted:
Fri, 02/16/2024 - 14:25 EST
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Commit To Purchase Astria Therapeutics At $10, Earn 31.8% Annualized Using Options
posted:
Thu, 02/15/2024 - 14:47 EST
by:
Nasdaq Options
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#Options
,
#StockOptions
,
#NasdaqOptions
Repare Therapeutics Inc. (RPTX) Soars 8.8%: Is Further Upside Left in the Stock?
posted:
Tue, 02/13/2024 - 04:45 EST
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Y-mAbs Therapeutics, Inc. (YMAB) Moves 9.5% Higher: Will This Strength Last?
posted:
Tue, 02/13/2024 - 04:10 EST
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Repare Therapeutics (RPTX) Shares Cross Above 200 DMA
posted:
Mon, 02/12/2024 - 16:57 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Pagination
Previous page
‹‹
Page 7
Next page
››